Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05733975 · ClinicalTrials.gov registry record · NA
Decision Making Support for Parents and Caregivers
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT05733975: Completed NA study, sponsored by Duke University.
NCT05733975 is a NA study that has completed, run by Duke University. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05733975, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
The purpose of this study is to test the feasibility and acceptability of a tool to support decision making for parents of critically ill infants.
Primary Outcome
Intervention and study procedures considered feasible if infant enrollment rate is greater than or equal to 50%.
Interventions
- OTHER Decision Making Guide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2023-05-02 |
| Est. Completion | 2024-01-29 |
| Phase | NA |
What the finished NCT05733975 record still lists
NCT05733975 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Decision Making Guide is the first listed.
NCT05733975 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05733975 about?
NCT05733975 is a clinical study titled "Decision Making Support for Parents and Caregivers". The purpose of this study is to test the feasibility and acceptability of a tool to support decision making for parents of critically ill infants.
What is the current status of trial NCT05733975?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2023-05-02. Estimated completion is 2024-01-29.
What interventions are being tested in trial NCT05733975?
The interventions under investigation include: Decision Making Guide (OTHER).
Who is sponsoring clinical trial NCT05733975?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05733975's enrollment target sits among peer trials
104 836th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI